Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 52022PC0338

    Initiative summary:
    The EU legislation provides high safety and quality standards for blood, tissues and cells. The initiative aims to update the current EU rules for scientific and technological developments, including accommodating innovative therapies. It will also address the (re-)emergence of communicable diseases, including lessons learnt from the COVID-19 pandemic, as well as increasing commercialisation and globalisation of the sector, thereby contributing to a stronger health Union.
    EuroVoc thesaurus:
    health policy; blood transfusion; cytology; substance of human origin; therapeutics; stem cell; artificial reproduction; health control; safety standard; quality standard